Background There is concern that selective serotonin reuptake inhibitors (SSRIs) considerably increase bleeding risk in patients taking anticoagulants. end result of major bleeding, the aHR for SSRI users versus those not taking SSRIs was 1.13 (95% CI, 0.62C2.06) for rivaroxaban; for warfarin, the aHR was higher, at 1.58 (95% CI, 0.96C2.60) but not statistically significantly… Continue reading Background There is concern that selective serotonin reuptake inhibitors (SSRIs) considerably